drugset / Trial / NCT06122831
A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF)
NaSingle-groupOpen-labelTreatment
Summary
This is an open, single-arm, multi-center clinical study designed to evaluate the efficacy and safety of TQ05105 Tablets combined with TQB3617 Capsules in patients with intermediate- and high-risk Myelofibrosis.
Timeline
- Start
- 2023-12-12
- Primary completion
- 2026-12
- Completion
- 2027-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TQ05105 | Small molecule | — | Oral |
| Subject | TQB3617 | Unknown | — | Oral |